Softhale

Diepenbeek, Belgium Founded: 2016 • Age: 10 yrs Acquired By Sino Biopharmaceutical
Inhalation devices for targeted drug delivery to lungs are developed.

About Softhale

Softhale is a company based in Diepenbeek (Belgium) founded in 2016 was acquired by Sino Biopharmaceutical in March 2021.. The company has 7 employees as of December 31, 2021. Softhale offers products and services including Softhaler. Softhale operates in a competitive market with competitors including MannKind Corp, Impel NeuroPharma, Alexza, OptiNose and Qnovia, among others.

  • Headquarter Diepenbeek, Belgium
  • Employees 7 as on 31 Dec, 2021
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Softhale
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
    $-9.66 M (USD)
    -12
    as on Dec 31, 2020
  • EBITDA
    $-9.65 M (USD)
    -12
    as on Dec 31, 2020
  • Latest Funding Round
  • Investors
  • Employee Count
    7

    as on Dec 31, 2021

  • Acquired by
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Softhale

Softhale offers a comprehensive portfolio of products and services, including Softhaler. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Delivers medications to lungs via ultra-fine mist for respiratory treatment.

Funding Insights of Softhale

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Softhale

Softhale has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Sino Biopharmaceutical. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Generics for cardio-cerebral diseases and hepatitis are developed and manufactured.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Softhale

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Softhale

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Softhale Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Softhale

Softhale operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MannKind Corp, Impel NeuroPharma, Alexza, OptiNose and Qnovia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of small-molecule drugs
domain founded_year HQ Location
Intranasal delivery technology for CNS diseases is developed.
domain founded_year HQ Location
Developer of products for the treatment of acute and intermittent conditions
domain founded_year HQ Location
Developer of smart devices for nasal drug delivery
domain founded_year HQ Location
Inhaled drug delivery devices are developed for pharmaceuticals.
domain founded_year HQ Location
Therapeutics for cardiopulmonary diseases are developed using inhaled therapies.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Softhale

Sino Biopharmaceutical’s Acquisition of Softhale
Globallegalchronicle4 years ago
SOFTHALE NV Announces New Board Member
Biospace7 years ago

Frequently Asked Questions about Softhale

When was Softhale founded?

Softhale was founded in 2016.

Where is Softhale located?

Softhale is headquartered in Diepenbeek, Belgium. It is registered at Diepenbeek, Limburg, Belgium.

Who is the current CEO of Softhale?

Jan-Torsten Tews is the current CEO of Softhale.

How many employees does Softhale have?

As of Dec 31, 2021, the latest employee count at Softhale is 7.

What does Softhale do?

Softhale was established in 2016 in Diepenbeek, Belgium, within the pharmaceutical sector. Focus is placed on the development of Soft Mist Inhalation devices, which facilitate the delivery of drugs to the lungs for respiratory disease treatment. The technology is designed to navigate the throats natural curve and permit unhurried inhalation of medication. Operations center on advancing inhalation-based drug administration methods.

Who are the top competitors of Softhale?

Softhale's top competitors include MannKind Corp, OptiNose and Impel NeuroPharma.

What products or services does Softhale offer?

Softhale offers Softhaler.

Who are Softhale's investors?

Softhale has 1 investor. Key investors include Sino Biopharmaceutical.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available